Ocugen, Inc. filed Definitive Additional Materials on November 6, 2026, notifying stockholders that a previously adjourned special meeting will be reconvened virtually on December 22, 2026, to vote on a proposed 250,000,000-share increase to the company's authorized common stock.
A group of trustees and related entities filed an amended beneficial ownership statement with the SEC on November 6, 2026, disclosing their holdings of Hyatt Hotels Corporation Class B Common Stock as of a triggering event dated November 4, 2026.
Irenic Capital Management LP and affiliated reporting persons filed a Schedule 13G on November 6, 2026, disclosing beneficial ownership of 8,410,009 shares of Apollo Commercial Real Estate Finance, Inc. common stock as of October 30, 2026.
Clean Energy Technologies, Inc. filed a preliminary proxy statement on November 6, 2026, notifying stockholders of a virtual annual meeting scheduled for December 17, 2026, at which three proposals will be put to a vote.
HeartSciences Inc. filed Definitive Additional Materials with the SEC on November 6, 2026, supplementing prior proxy communications related to its all-stock merger agreement with Fortitude Mining Holdings, Inc., and including social media posts published by an executive officer of Digital Currency Group, Inc.
Mangoceuticals, Inc. filed a preliminary proxy statement on November 6, 2026, calling a combined 2025 and 2026 Annual Meeting of Stockholders to be held on Wednesday, December 30, 2026, at the company's Dallas, Texas headquarters.
Big Digital Energy, Inc. filed a Form S-3 registration statement with the SEC on November 6, 2026, covering the resale of up to 442,899 shares of common stock by a selling stockholder whose debt was converted into equity on September 18, 2026.
Clean Energy Technologies, Inc. filed a Form 8-K on November 6, 2026, disclosing that it entered into a securities purchase agreement with FuFront AI Pte. Ltd. on November 4, 2026, resulting in the issuance of a $2,000,000 convertible promissory note.
T3 Defense Inc. filed a current report on November 6, 2026, disclosing that it completed the acquisition of KeepZone AI Inc. on November 4, 2026, through an amended Stock Purchase Agreement with Israeli seller Nexera Technologies Ltd.
Mangoceuticals, Inc. filed a Form 8-K on November 6, 2026, disclosing that the sole holder of its Series B Convertible Preferred Stock approved, by written consent on November 2, 2026, the terms of a proposed 8% Series D Convertible Cumulative Preferred Stock and an …